Pharmacy2U posts Â£16m loss for 2018-19
Online pharmacy business Pharmacy2U saw a 41 per cent increase in revenue to £60.7 million for the year to the end of March 2019 (2018: £43.2m), but still posted a loss of £16m for the year.
Loss before interest, tax, depreciation and amortisation increased by £4.4m to £14.4m as a result of “significantly higher investment in NHS acquisition marketing”. LIBTDA before marketing costs was £2.7m, according to its annual report for 2018-19.
The number of NHS prescription items dispensed rose 80 per cent to 5,322,000 in 2018-19 from 2,957,000 in 2017-18, while the number of NHS patients registered with Pharmacy2U rose 21 per cent to 331,000 (273,000 in 2017-18).
The group reported significant progress was made during the year to reduce operating costs through scale and operational efficiencies, which largely mitigated the impact of the reductions in NHS reimbursement.
Pharmacy2U was established as the UK’s first internet pharmacy in 1999, and now claims to be the country’s largest NHS contracted online pharmacy. The group secured a £40m equity investment in 2018 led by private equity firm G-Square Capital. The investment is being used to fund a second automated dispensing facility.
The group’s core strategy is focussed around providing a fully managed repeat prescription delivery service. The annual report says the group expects profitability to increase through the remainder of this financial year and beyond.
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
Pharmacy teams could soon be wearing transparent masks
The DHSC said the masks could be used by staff when talking to deaf patients who need to lip-read and dementia sufferers.
1 Min Article
One in 50 scripts need to be modified by pharmacists
Community pharmacists modify almost one in 50 prescriptions to avoid a potential drug-related problem (DRP), according to a Dutch study.
2 Min Article
More than 1 in 10 pharmacists told not to wear PPE, says PDA
More than one in 10 pharmacists have been asked to re-use PPE, with similar numbers saying they were actively discouraged from wearing it.
3 Min Article
Covid treatment for people who can't have vaccine on horizon
People who can't have a vaccine because they are immunocompromised may get access to a Covid-19 treatment.
1 Min Article
Cutting costs leads to profit boost for Lloyds parent company
LloydsPharmacy parent company McKesson saw a 16 per cent profit rise in its European division in the most recent financial quarter.
2 Min Article
OTC Omeprazole tablets 20mg: an opportunity for pharmacy
This module highlights a new opportunity to treat heartburn and reflux in the pharmacy with Omeprazole 20mg, which is newly available for customers to purchase OTC.
22 Min Module
Relief from the nasal symptoms of allergy
With NHS England advising that OTC products should no longer be prescribed to treat mild-to-moderate hayfever, pharmacy’s role in supporting sufferers is more important than ever. This module includes self-care advice and product recommendations to aid customer conversations.
15 Min Module